BioMarin Pharmaceutical Inc. (BMRN) Investment Research Dashboard
About BioMarin Pharmaceutical Inc. (BMRN) stock analysis
Get live BMRN stock price $60.27, comprehensive BioMarin Pharmaceutical Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BMRN stock data and investment insights.
Loading chart data...
BioMarin Pharmaceutical Inc. (BMRN) Overview
BioMarin Pharmaceutical Inc. (BMRN) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, BMRN trades at $60.27 with a market capitalization of 11.65B . Over the past 52 weeks, BMRN has traded between $49.26 and $66.28 , with the current price positioned at approximately 65% of this range . The stock currently ...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 11.65B
- Current price: $60.27
- 52-week range: $49.26 - $66.28
- P/E ratio: 28.98
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutica...
Company Information
- CEO
- Alexander Hardy
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3221
Contact Information
- Website
- https://www.biomarin.com
- Address
- 770 Lindaro Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 29.0)
✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BioMarin Pharmaceutical Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BioMarin Pharmaceutical Inc.
- ⚠Investors should consider how BioMarin Pharmaceutical Inc. fits within their overall portfolio allocation
Market Cap
11.65B
P/E Ratio (TTM)
28.98
Beta
0.24
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BMRN with peer companies:
- Price
- $168.05+0.62% (1D)
- Market cap
- 12.04B
- Price
- $84.12+0.12% (1D)
- Market cap
- 16.48B
- Price
- $55.81+0.79% (1D)
- Market cap
- 14.03B
- Price
- $81.48-0.55% (1D)
- Market cap
- 9.66B
- Price
- $551.25+1.24% (1D)
- Market cap
- 12.71B
- Price
- $55.63+2.89% (1D)
- Market cap
- 22.07B
- Price
- $41.08-0.70% (1D)
- Market cap
- 8.47B
- Price
- $11.57+0.70% (1D)
- Market cap
- 197.91M
- Price
- $188.07-0.61% (1D)
- Market cap
- 39.98B
- Price
- $71.62+0.03% (1D)
- Market cap
- 11.21B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- -0.1%
- NASDAQ
- -0.1%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.